oxygen (o 2 ) acts as a potent upstream regulator of cell function. In both physiological and pathophysiological microenvironments, the o 2 concentration is not uniformly distributed but instead follows a gradient that depends on distance from oxygen-carrying blood vessels. such gradients have a particularly important role in development, tissue regeneration, and tumor growth. In this protocol, we describe how to use our previously reported gelatin-based o 2 -controllable hydrogels that can provide hypoxic microenvironments in vitro. the hydrogel polymeric network is formed via a laccase-mediated cross-linking reaction. In this reaction, laccase catalyzes diferulic acid (diFa) formation to form hydrogels with an o 2 -consuming reaction. cells, such as cancer or endothelial cells, as well as tumor/tissue grafts, can be encapsulated in the hydrogels during hydrogel formation and then analyzed for cellular responses to 3D hypoxic gradients and to elucidate the underlying mechanisms governing these responses. Importantly, oxygen gradients can be precisely controlled in standard cell/tissue culture conditions and in vivo. this platform has been applied to study vascular morphogenesis in response to hypoxia and to understand how oxygen gradients mediate cancer cell behavior. Herein, we describe the means to validate the assay from polymer synthesis and characterization-which take 1-2 weeks and include verification of ferulic acid (Fa) conjugation, rheological measurements, and o 2 monitoring-to the study of cellular responses and use in rodent models. time courses for biological experiments using this hydrogel are variable, and thus they may range from hours to weeks, depending on the application and user end goal.
IntroDuctIon
Oxygen (dioxygen, O 2 ) is a key molecule vital for the existence of all multicellular organisms. Variations in O 2 are known to control signaling cascades that lead to metabolic and phenotypic changes. As partial pressure of O 2 falls below 5%, herein defined as hypoxia (Table 1) , a myriad of cellular and systemic adaptations commence.
During tumor development and progression, a low-O 2 environment manifests when a tumor outgrows the existing O 2 supply, leading to the upregulation of numerous important factors, perhaps most notably hypoxia-inducible factor 1-α (HIF-1α). HIF-1α upregulation has been correlated with negative patient outcomes in many cancers, such as sarcoma 1 , prostate cancer 2 , and squamous cell head and neck cancer 3 . Exacerbating such negative outcomes, tumors with high levels of HIFs are resistant to chemotherapy and radiation therapy because of limited perfusion 4 . At the cellular level, hypoxia has been shown to induce cancer cell migration 5, 6 , extracellular matrix (ECM) modification 7 , and recruitment of blood vessels 8 . In sarcoma, low O 2 leads to faster cell migration via HIF-1α (ref. 5) , which upregulates collagen modifiers such as lysl oxidase, procollagen-lysine, and 2-oxoglutarate 5-dioxygenase 2 (PLOD2) 5, 7 . Hypoxic conditions in the tumor environment have also been shown to upregulate the secretion of angiogenic factors such as vascular endothelial growth factor (VEGF) 9 . Overall, the hypoxic microenvironment regulates multifaceted pathways that are critical to the development and progression of cancer.
A similar mechanism by which hypoxia upregulates VEGF and other effectors of cancer cell function in the tumor microenvironment has also been shown to affect various vascular diseases and to modulate wound healing and tissue regeneration. For example, hypoxic upregulation of VEGF secretion has been documented in macular degeneration, wherein high levels of VEGF cause uncontrolled blood vessel growth, resulting in poorly formed or leaky vessels, which can lead to blindness [10] [11] [12] . In wound healing, hypoxia plays a critical role in the enhancement of blood vessel recruitment and inflammatory responses. Here, a reduced blood flow at the injury site leads to a locally low-O 2 environment, which in turn initiates angiogenesis and wound healing. Further, the hypoxic environment in wounded blood vessels increases the expression of intercellular adhesion molecule 1, a key factor in recruiting endothelial progenitor cells 13, 14 and immune cells 15 to the injury site. Diseases with underlying HIF-1 overexpression can lead to chronic wounds and fibro-proliferative disorders, as well as to hypertrophic scars 16 . Conversely, low levels of HIF-1 are commonly seen in diabetic ulcers and in elderly patients, which may lead to impaired wound healing 17 .
Responses to hypoxia are required for the normal development of the vascular system 18, 19 . In early embryonic development, fastgrowing tissues must coordinate growth with O 2 delivery. O 2 in this environment is critically low and acts as a signal to stimulate vascular growth 20 and endothelial cell differentiation 21 . It has also been suggested that, during embryonic vessel development, regions of relative hypoxia attract growing blood vessels 22 . During the early stages of embryogenesis, a primitive vascular pathway is formed through vasculogenesis, in which progenitor cells form an immature vascular plexus 20 . Once this primitive vascular network is formed, endothelial cells form new capillaries via angiogenesis. This pathway stimulates VEGF and other angiogenic factors via O 2 -controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo Our hydrogel polymeric network is formed by diFA formation in a laccase-mediated cross-linking reaction with O 2 consumption (Fig. 1a) . After completion of the reaction, the low DO level is maintained through O 2 consumption by the cells or tissue 38 . The cross-linking reaction allows the cells to be rapidly exposed to a hypoxic environment, without the need to wait for a spontaneous (cell-mediated) gradient to form. This is beneficial because it takes time for these cell-mediated gradients to form spontaneously, and the construct cannot be guaranteed to remain mechanically stable. A biomimetic extracellular environment is critical for research into vascular differentiation and development, in which 3D networks are formed through cell-matrix interactions, including adhesion and degradation [39] [40] [41] . In the case of cancer cells, O 2 gradients can form in sufficiently thick 3D tissue, but the gradients are transient and very difficult to control. Finally, it should also be noted that rapid, predictable O 2 gradients cannot form when encapsulating tissue grafts or when transplanting non-O 2 -controllable materials in vivo. Our platform circumvents these pitfalls by rapid O 2 consumption during hydrogel formation via a laccase-mediated cross-linking reaction. When the chemical reaction is completed, the O 2 -consuming reaction is terminated and atmospheric O 2 diffusion begins. In vitro, the O 2 levels within the gel can be simply controlled by varying the thickness of the hydrogel construct. The gradients in the gel can last up to 1-2 weeks, allowing for long-term hypoxia experiments while minimizing the generation of reactive oxygen species that may be elicited through rapid reoxygenation. These gels can be fabricated in traditional polystyrene 96-well plates, and once cells are encapsulated or microtissues are embedded, the constructs are cultured with traditional cell culture media in a standard incubator. The DO levels and gradients are controlled by varying hydrogel thickness in a volume-dependent manner in wells of 96-well plates (e.g., nonhypoxic hydrogels, 45 µl; hypoxic hydrogels, 90 µl). In addition to using conventional cell culture equipment, these gels use a small volume of polymer solution, typically 45-100 µl, and therefore small volumes of reagents can be used for molecular biology assays such as PCR, histology, and immunofluorescence analysis. These gels are optically clear and therefore are ideal for the real-time measurement of O 2 and cell migration, as well as in situ staining for immunofluorescence imaging. Furthermore, the platform can be used to screen small-molecular inhibitors 5 .
In vivo experiments using hydrogels as therapeutics or to study the effects of O 2 gradients in disease models may also be designed and performed (Box 1).
Cells encapsulated in hydrogels can be administered to mice. O 2 gradients and severity of hypoxia in these cell grafts are dependent on two main factors in vivo: (i) hydrogel volume and (ii) surrounding tissue O 2 concentration. Hydrogels with larger relative volumes will have a more severely hypoxic core, and thus a steeper O 2 gradient. If hydrogels are injected or implanted in tissues with high relative O 2 , steep gradients may be obtained. Those tissues with lower relative O 2 levels will exhibit shallower gradients 38 . We have demonstrated that insights into the role of varying O 2 during tumor growth, vascular development 42 , and angiogenesis 38, 43 can be acquired using these hydrogels. inherent advantages for use as a tool for biological experimentation. Gelatin is produced through denaturation (partial hydrolysis) of collagen, a critical ECM protein found in nearly all tissues throughout the human body. Thus, gelatin possesses bioactive characteristics with broad implications for many biological applications of numerous cell and tissue types. In particular, the presence of integrin-mediated cell adhesion motifs and the amenability to cell-mediated proteolytic degradation highlight the underlying advantages of the use of a gelatin backbone. Such properties alleviate the need for user-defined optimization of the concentration of cell adhesion motifs and degradable add-ins, leading to a highly biomimetic culture system. Because gelatin is naturally derived, there is a certain degree of batch-to-batch variability, as with any natural polymer. However, widespread use and characterization of gelatin both in 2D culture systems 44 and as 3D platforms [45] [46] [47] , along with a high level of bioactivity, motivate its use in our system.
Control over O 2 tension in our Gel-HI hydrogel necessitates O 2 consumption. In addition, in order to develop gelatin-based culture systems, chemical functionalization to achieve a cross-linking mechanism is necessary, as gelatin thermally cross-links only below physiological temperatures. These two needs define our design approach in developing this system. Importantly, a large number of molecules can be conjugated because a high number of chemically active functional groups is available, making chemical functionalization simple. In particular, for our application, primary amines are abundant. Less abundant are biocompatible reactions that include physiologically relevant O 2 consumption. Laccase, an enzyme derived from mushrooms (among other select fungi and trees), has particular specificity in catalyzing reactions between phenol-containing molecules 48 . Specifically, laccase can catalyze the four-oxygen reduction of O 2 to H 2 O, which results in oxidation of two phenol-containing molecules. Similar to laccase, other enzymes can be adopted to create hypoxia-inducible hydrogel matrices (e.g., tyrosinase and glucose oxidase, which consume molecular O 2 during cross-linking of phenolic molecules). Our choice of phenolic moiety required the presence of a carboxyl group opposite the phenol to facilitate chemical conjugation to the gelatin backbone. FA satisfies our design criteria, and thus was conjugated to the gelatin backbone by using N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC)/Nhydroxysuccinimide (NHS) chemistry. The FA-conjugated gelatin polymers form hydrogels through diFA formation in a laccasemediated reaction, resulting in bioactive and O 2 -controllable Gel-HI hydrogels.
It is critical to understand how O 2 tension and O 2 gradients are regulated in Gel-HI hydrogels. As discussed above, Gel-HI hydrogels are used in standard incubators and culture plates. In such conditions, passive diffusion of atmospheric (~21%) O 2 is an important consideration. Such diffusion acts to increase the O 2 tension in the culture microenvironment. With that, two elements of the system act to decrease O 2 tension: (i) laccase-mediated O 2 consumption and (ii) cell-mediated O 2 consumption. An initial decrease is induced by the laccase-mediated cross-linking reaction, and in acellular experiments, following completion of the reaction, the hydrogel microenvironment returns to atmospheric conditions within hours. Hydrogels containing encapsulated cells maintain low-O 2 (<5% is considered hypoxic) conditions for 3-7 d in culture. Maintenance of low-O 2 conditions is highly dependent on cell concentration and cell type 5, 38 . In general, higher cell concentrations lead to prolonged maintenance of hypoxia. In addition, cell types vary in rates of O 2 consumption, and thus understanding cell O 2 needs is critical to experimental design. These parameters should be considered as key factors in efforts to accurately mimic the native tumor (or ischemic) microenvironment, as cellular activities are highly variable within the dynamic O 2 microenvironment. Growing evidence has demonstrated that transcription factors (e.g., HIFs), which regulate cellular activities, accumulate when the cells or tissues are exposed to hypoxia 10 . For example, cells may change their metabolism to reduce O 2 consumption by upregulating GLUT gene expression in hypoxic environments. In addition, HIFs activate various  crItIcal step The stained tissues are light-sensitive. Keep the explants in the dark by wrapping the samples in aluminum foil. (b) Gradient measurement in vivo (following subcutaneous injection) ! cautIon Needle-type O 2 microsensors are extremely fragile. Take extra care when handling microsensors. Although they are protected by the needles, the microsensor portion is <50 µm in diameter, so it may break if subjected to impact.  crItIcal Needle-type O 2 microsensors are an invasive tool for measuring O 2 gradients. As such, these measurements may affect the integrity of the hydrogel. Thus, we suggest that gradient measurements serve as the end point of a given experiment.  crItIcal Calibrate the microsensors to mouse body temperature. During readings, the body temperature will be slightly lower than normal because of the anesthesia. Keep the mice on the heating pad to maintain mouse comfort.
(i) Attach a needle-type O 2 microsensor to the manual micromanipulator according to the manufacturer's instructions.
(ii) Place the temperature probe under the mouse's body to monitor body temperature in real time.
(iii) Mark the proximal and distal ends of the hydrogel.
(iv) Puncture the mouse skin with the needle microsensor.
(v) Using the fine-adjustment knob on the micromanipulator, move the microsensor into the distal end of the hydrogel.  crItIcal step In vivo, O 2 measurements take time to equilibrate (~30-45 min). It is critical to achieve a stable reading before moving on to another measurement. (vi) Using the fine-adjustment knob, move the sensor a predetermined distance to make another measurement. Continue until all measurements have been made. (continued) cellular processes, including metabolism, proliferation, invasion and metastasis, and tumor angiogenesis. In our previous study, we also demonstrated that mouse sarcoma cultured within 3D hypoxic matrices upregulated numerous hypoxia-related genes including GLUT-1, MMP genes, and VEGF. Furthermore, there are variations in the cellular O 2 consumption rate, depending on the cell type and number within artificial hypoxic microenvironments. Thus, we should consider the variations in the cellular metabolism within artificial hypoxic microenvironments as a critical design parameter throughout experiments in this hydrogel system. Last, because of the constant and delicate balance between active O 2 decreases and passive O 2 increases, the volume of the hydrogel has a substantial role in in vitro assays. Steepness of O 2 gradients and maintenance of hypoxic conditions rely heavily on the volume and, perhaps more specifically, on the thickness of the hydrogel. In smaller-volume (decreased thickness) hydrogels, atmospheric concentrations of O 2 diffuse quickly throughout the gel, resulting in higher O 2 levels with a shallow gradient. Largervolume (increased thickness) hydrogels diffuse O 2 more slowly throughout the entire volume, resulting in hypoxic conditions with substantial O 2 gradients. In addition to O 2 tension, other important ECM parameters, such as stiffness and degradability, can be controlled by simply adjusting polymer or enzyme concentration. Further adjustment through secondary cross-linking with an additional enzyme, microbial transglutaminase, has been described 29, 43 . In this article, we describe the detailed protocol for synthesis, characterization, manipulation, and application of our versatile Gel-HI hydrogels. Limitations in 3D hypoxic cell culture and O 2 gradient studies are alleviated by the use of Gel-HI hydrogels, with a wide range of use both in vitro as a culture platform and in vivo as a cell delivery vehicle and as an acellular therapeutic.
Applications of the protocol
Cancer. Hypoxia is a key regulator affecting cell migration, ECM modification, and blood vessel recruitment during tumor development, growth, and metastasis. Gel-HI hydrogels allow us to simultaneously study the effects of a wide range of O 2 levels, whereas most studies focus on a fixed O 2 level, typically drawing comparisons between experiments conducted within the severe hypoxic range (0.5-1%) and those conducted at atmospheric (21%) O 2 . One of the key benefits of this platform is the DO gradient along the hydrogel depth, which uniquely provides opportunities to study how gradients regulate cell behavior in vitro in three dimensions. Moreover, this platform not only allows for the use of conventional cell and molecular biology assays, but it also permits real-time imaging to track single cancer cell proliferation and study motility/migration. Conventional hypoxic platforms, such as chambers, do not allow for a controlled gradient to be formed, and are prohibitive for live-cell imaging because of the chamber's size, as it cannot fit into conventional microscope setups. Tumor sections can also be encapsulated in the hydrogel, and the migration of cells out of the tumor can be documented. This allows the user to study cells in pathophysiologically relevant O 2 gradients using real-time imaging to elucidate pathways that lead to cancer cell migration and potential metastasis.
Vascular applications.
Not surprisingly, the vascular regeneration niche has been studied in great detail, owing to the high mortality and morbidity of cardiovascular disease in the developed world 49 . Complex mechanisms have been uncovered and described relating to the interplay between multiple cell types (including interactions between endothelial cells and mural cells 50 ), growth factors 51 , ECM properties 40 , and O 2 tension 52 . Specifically, as detailed above, hypoxic conditions have been shown to trigger vascular formation and growth during embryonic development, various vascularrelated disorders, and cancer. However, studying the effects of O 2 tension and O 2 gradients in a 3D microenvironment was not possible until the development of Gel-HI hydrogels. Gel-HI hydrogels facilitate studies in a highly biomimetic experimental system by harnessing the endothelial cell's own vasculogenic capacity. Many platforms that are used to study vascular network formation require the addition of hyperphysiological concentrations of proangiogenic growth factors or an engineered 'angiogenic' or 'vasculogenic' cocktail of factors 39, 53 . However, encapsulation of vascular cells in Gel-HI leads to cell-mediated production of angiogenic growth factors and subsequent vascular network formation. Thus, Gel-HI hydrogels provide a system that more closely mimics the native regenerative niche than do other culture systems. For example, our laboratory has shown that early vascular cells derived from induced pluripotent stem cells of diabetic patients can generate lumenized networks in hypoxic Gel-HI hydrogels, indicating their responsiveness to hypoxic pathways 42 .
Limitations of the platform
No biomaterial is without limitations, whether in function or application. Several limitations have been briefly mentioned in the preceding text, which we will again describe here. First, batch-to-batch variability exists with these hydrogels, as with any naturally derived polymeric hydrogel. Even with a relatively simple polymer synthesis protocol, variability can be seen in an academic lab setting. As such, it is critical to maintain consistency in technique throughout every step of the process, including synthesis, purification, storage, and particularly cell encapsulation. To ensure reproducibility, we recommend careful analysis of polymer properties before cell/tissue encapsulation experiments. Enzymatic cross-linking is particularly sensitive to temperature and timing, both of which are critical to maintaining experimental reproducibility. Hydrogel precursor solutions, particularly laccase, may become cytotoxic outside of the concentration ranges suggested by this protocol. Laccase is sensitive to storage conditions and may lose activity with extended storage in aqueous solution (>2-3 months). In addition, because the matrix can be degraded in a cell-mediated manner, over the course of the experiment mechanical properties are subject to cell-mediated change. This property of hydrogels is critical to many applications but can serve as a limitation to culture time. If left in culture long enough (usually >5 d), the matrix may completely degrade. Furthermore, cell culture time may vary with cell type and encapsulation concentration.
Experimental design
A vast array of powerful experiments can be developed by following the steps described in this protocol. Examples of several end-point analyses are included, which can be used or omitted as researchers tailor the experimental design to fit their needs. (Fig. 1) . Expertise in cell culture techniques is a necessity for performing experiments using this protocol. In addition, experience with microscopy, immunofluorescence staining, and microbiological techniques will aid in the range of experiments possible with this protocol. Background in materials science and polymer synthesis is suggested, but not required, as the synthesis protocol is relatively simple.
MaterIals

REAGENTS
! cautIon Wear suitable personal protective equipment, including a lab coat, chemical gloves, and safety goggles, when handling chemical reagents. Please refer to the appropriate material safety data sheet provided by the manufacturer.  crItIcal All reagents should be maintained at listed storage conditions and should not be used after manufacturer-defined expiration date.
Synthesis and characterization of Gtn-FA polymers
Gelatin, type A from porcine skin, <300 bloom (Sigma-Aldrich, cat. no. G2500; store at room temperature, If purchased from other suppliers, some properties of polymers and hydrogels may vary (e.g., conjugation efficiency of FA, solubility of polymer, and phase transition time and mechanical properties of hydrogels) because of the differences in the purity grade. It is advisable to characterize each polymer batch and the resultant hydrogels to ensure reproducibility of results. In particular, laccase is subject to manufacturer availability. Alternative laccase sources may be used. In such cases, ensure that the activity and cross-linking/O 2 consumption properties match those of previously published results 38 .
Validation of polymer
Deuterium oxide (D 2 O; Sigma-Aldrich, cat. no. 151882; store in a dry place at room temperature) Polymer and cross-linker preparation Dulbecco's PBS (DPBS; Gibco, cat. no. 14040133; store at room temperature) Cytotoxicity of gelatin-g-ferulic acid (Gtn-FA) and laccase (XTT assay) Newborn human foreskin fibroblasts (Global Stem, cat. no. GSC-3002) ! cautIon The cell lines used in your research should be regularly checked to ensure that they are authentic and that they are not infected with mycoplasma. Media base (DMEM; Thermo Fisher Scientific, cat. no. 11965092; store at 4 °C) Triton X-100 (Sigma-Aldrich, cat. no. X100; store at room temperature) ! cautIon Triton X-100 is hazardous and toxic, and it may induce skin irritation, serious eye damage, and respiratory irritation if contacted or inhaled. Always wear eye shields, face shields, full-face respirator (US), and gloves when handling Triton X-100 to avoid any direct contact.
Immunofluorescence staining
Paraformaldehyde (PFA; Sigma-Aldrich, cat. no. 158127; store the powder at 4 °C, and store the solution at 20 °C) ! cautIon PFA is a potent fixative and it is hazardous. Avoid any direct contact and wear appropriate personal protective equipment. Triton X-100 (Sigma-Aldrich, cat. no. X100; store it at room temperature) 
In vivo subcutaneous injection
Mice, 6-10 weeks old, C57/6 female (Charles River, strain code 027; for acellular applications) or NU/NU (Charles River, strain code 088 (homozygous); for human cell applications) ! cautIon Any experiments involving live rodents must conform to relevant institutional and national regulations.  crItIcal The animal study used to produce the example results shown was performed using one of the protocols (RA15A152, MO15A154, or MO16A284) as approved by the Johns Hopkins University Institutional Animal Care and Use Committee (RA, rat protocol; MO, mouse protocol).
• •
Cancer cell isolation Isolate cells from murine soft-tissue sarcomas, as described in Yoon et al. 54 and Kirsch et al. 55 .
Cancer cell culture medium Filter cancer media base supplemented with 50 µg/ml penicillin-streptomycin and 10% (vol/vol) heat-inactivated FBS using a 0. 
7|
After the reaction, transfer the solution to a dialysis membrane (molecular weight cutoff = 3,500 Da) and dialyze at 40 °C against 5 liters of deionized water for 3-5 d in a chemical safety fume hood. Change water at least twice daily.  crItIcal step FA should be removed completely, as residual FA (free FA molecules) may influence hydrogel properties because of disruption of diFA formation in the Gtn-FA polymer backbone by the free FA molecules; e.g., it might result in a slow phase transition or in hydrogels with poor mechanical properties. Dialysis is complete when the solution becomes colorless and transparent. If there is any free FA, the solution will be slightly yellow.  crItIcal step The solution should be purified by filtering with a 0.2-um-pore-size membrane to remove gelatin aggregates and other impurities before the freeze-drying step.
8|
After dialysis and purification (Step 7), freeze-dry to obtain Gtn-FA conjugates.  pause poInt Keep the product in a refrigerator at 4 °C until use. The product can be stored for up to 6 months. 
Validation of Gtn-Fa polymer • tIMInG 1-2 h 9| Chemical structures ( 1 H NMR).
Dissolve the Gtn-FA polymer solution in deuterium oxide (10 mg/ml) and acquire a 1 H NMR spectrum to confirm the structure (supplementary Fig. 1 ).
10|
Degree of substitution (DS) of FA. Dissolve Gtn-FA polymer (10 mg) in 1 ml of a mixture of DMSO and dH 2 O with a volume ratio of 1:1.
11|
Measure absorbance at the 320-nm wavelength using a UV/visible spectrometer.  crItIcal step For UV/visible measurements, the polymers and standard FA molecules should be dissolved in the cosolvent.  crItIcal step Ensure that the polymer and standard FA molecules are completely dissolved in the solvent.
12|
Calculate the concentration of the conjugated FA molecules from a calibration curve given by monitoring the absorbance of a known concentration of FA; standardize with the baseline measured using Gtn solution (10 mg/ml). 
14|
Remove the culture medium and add fresh medium including polymers (0.63-10.0 mg/ml) and laccase (1.6-25 U/ml).
15| After 24 h, remove the medium and culture the cells in the presence of the XTT solution (20% (vol/vol)) dissolved in medium for 4 h.  crItIcal step The XTT solutions are light-sensitive. Keep the solutions in the dark by wrapping the samples in aluminum foil.
16|
For quantitative analysis, place the medium in a 96-well plate and read it in a microplate reader at the 450-nm wavelength.
17| Determine cell viability as a percentage relative to the viability of control cells (nontreated cells; defined as 100% viable).
polymer and cross-linker preparation • tIMInG 1-2 h 18| Prepare Gtn-FA (4.0-6.7 wt%) and laccase (25-100 U/ml) stocks by dissolving in DPBS (pH 7.4).  crItIcal step Keep stock solutions in a freezer at −20 °C and incubate the solutions at 37 °C for 15 min before use. Incubate the laccase stock solution at 37 °C for 5 min before use.  crItIcal step Maintain small-volume aliquots of laccase to avoid repeated freeze-thaw cycles.  pause poInt Stock solutions can be prepared for later use. Laccase stock solutions should be used within 2-3 months.
rheological analysis of Gel-HI hydrogels • tIMInG 2-3 h 19| Prepare the Gel-HI hydrogel solution by mixing Gtn-FA and laccase stock solutions at a 3:1 (Gtn-FA/laccase) ratio.  crItIcal step Mix the solutions by pipetting and mild shaking to prevent bubble formation.
20|
Pipette 200 µl of Gel-HI hydrogel solution onto 25-mm plate geometry in the instrument (TA Instruments, model no. RFS3).
? troublesHootInG
21|
To monitor elastic modulus (G′) and viscous modules (G″), perform dynamic time sweeps on hydrogels at 10% of strain and a frequency of 0.1 Hz at 37 °C.  crItIcal step Maintain the polymer solution at 37 °C to avoid thermo-gelation.  crItIcal step Ensure that the hydrogels are flat and parallel to the plate in the instruments.  crItIcal step To prevent water evaporation in the hydrogels, keep the hydrogels with a solvent trap (purchased from TA Instruments). (i) Generate the desired tumors using your standard laboratory protocol (Fig. 2) .
22|
(ii) Slice a tumor to 1-mm thickness using standard laboratory technique. ? troublesHootInG Troubleshooting advice can be found in table 2. Gel-HI hydrogels provide a uniquely biomimetic microenvironment that can be used for a variety of applications. In particular, the ability to control hypoxic gradients and overall O 2 tension may be applied to vascular applications 38, 43 (Fig. 4) . Vasculogenesis and angiogenesis often rely on the hypoxic microenvironment to facilitate the formation or invasion of new blood vessels. We anticipate that Gel-HI hydrogels may provide novel insights into such vascular development and regenerative processes. This knowledge may be used to inform targets for drug discovery, as well as aid in the design of vascularized tissue constructs. Overall, the ability to mimic the physiological, or pathophysiological, microenvironments in vitro will probably provide a platform for continued innovation. Results are shown as the average of all cells tracked ± s.e.m. Significance levels were evaluated using a t-test: * P < 0.05; ^P < 0.01; # P < 0.001. Adapted with permission from Lewis et al. 5 , National Academy of Sciences.
For cancer research, Gel-HI hydrogels provide a powerful platform for studying single-cell responses to hypoxic gradients, such as matrix remodeling and cell migration 5 (Fig. 5) . As a display of the potential breadth of study, cellular mechanisms can be analyzed with standard cell and molecular biology techniques. The Gel-HI hydrogels can also provide a platform for analyzing tumor biopsies that can be grafted into the gel (Fig. 2) to analyze cell migration out of the graft into the surrounding hydrogel, as an in vitro corollary to tumor growth, migration, and potential metastasis (Fig. 6) . As a tool in cancer biology, Gel-HI hydrogels may identify novel pathways for tumor growth and migration induced only in hypoxic conditions, as well as provide a method of screening cancer therapeutics and determining potential pitfalls or unintended consequences that cannot be studied with standard in vitro platforms.
During in vivo implantation of the hydrogel, real-time O 2 measurements can be made using the needle-type O 2 sensor (Fig. 7) . After implantation of the hydrogel, an analysis of the vasculature can be performed to look at vascular recruitment to the wound, as well as the number of vessels (Fig. 8) 27 . If proper O 2 tension is maintained, recruitment should be clear under histological analysis and fluorescence staining. The translational potential of Gel-HI hydrogels is immense, as hypoxia governs production of many signaling molecules that may influence cell behavior. Overall, the Gel-HI hydrogels have a great potential either as 3D artificial hypoxic cellular microenvironments or as hypoxia-inducible acellular matrices for the treatment of vascular disorders. The HI hydrogels also provide an innovative platform as an engineered tumor microenvironment in which to study basic cancer biology and to screen drug candidates for better clinical outcomes in cancer treatment. In addition to the applications discussed, looking forward, we anticipate that the use of Gel-HI hydrogels will provide a new platform for innovation in the stem cell and developmental biology fields. We anticipate that studying the effects of developmentally relevant O 2 gradients will lead to conclusions previously unattainable with available research tools. Such revelations may lead to advances in tissue engineering and regenerative medicine, as well as accelerate the understanding of the role of hypoxic gradients in development and tissue regeneration. Commercially available needle-type oxygen sensors (PreSens) were used to measure partial pressure of oxygen over time both (a) subcutaneously and (b) intramuscularly in 10-to 12-week-old nude mice. Sensors remained stationary and readings equilibrated after ~60 min to 7.4 and 3.0% in the subcutaneous and intramuscular regions, respectively. A temperature probe was used concomitantly to ensure the accuracy of the oxygen readings. The animal study was performed using a protocol (MO16A284) approved by The Johns Hopkins University Institutional Animal Care and Use Committee.
